SinoMab BioScience Limited (3681.HK)

HKD 1.23

(4.24%)

Revenue Summary of SinoMab BioScience Limited

  • SinoMab BioScience Limited's latest annual revenue in 2023 was 1.36 Million CNY , down -66.15% from previous year.
  • SinoMab BioScience Limited's latest quarterly revenue in 2024 Q2 was 6.08 Million CNY , down 0.0% from previous quarter.
  • SinoMab BioScience Limited reported a annual revenue of 4.03 Million CNY in annual revenue 2022, down -84.87% from previous year.
  • SinoMab BioScience Limited reported a annual revenue of 26.65 Million CNY in annual revenue 2021, up 108.91% from previous year.
  • SinoMab BioScience Limited reported a quarterly revenue of -4.07 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • SinoMab BioScience Limited reported a quarterly revenue of 8.46 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of SinoMab BioScience Limited (2023 - 2017)

Historical Annual Revenue of SinoMab BioScience Limited (2023 - 2017)

Year Revenue Revenue Growth
2023 1.36 Million CNY -66.15%
2022 4.03 Million CNY -84.87%
2021 26.65 Million CNY 108.91%
2020 12.76 Million CNY 0.0%
2019 - CNY -100.0%
2018 1.48 Million CNY 0.0%
2017 - CNY 0.0%

Peer Revenue Comparison of SinoMab BioScience Limited

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD 99.718%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 99.974%